Black Rock Inc. Nurix Therapeutics, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 4,580,414 shares of NRIX stock, worth $95.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,580,414

Previous 4,643,736 1.36%

Holding current value

$95.6 Million

Previous $47.9 Million 40.5%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$7.77 - $15.66 $492,011 - $991,622	-63,322 Reduced 1.36%	4,580,414 $67.3 Million
Q4 2023 Feb 13, 2024	BUY	$4.25 - $10.71 $532,023 - $1.34 Million	125,182 Added 2.77%	4,643,736 $47.9 Million
Q3 2023 Nov 13, 2023	SELL	$7.86 - $10.08 $6,468 - $8,295	-823 Reduced 0.02%	4,518,554 $35.5 Million
Q2 2023 Aug 11, 2023	BUY	$8.7 - $13.28 $1.99 Million - $3.03 Million	228,237 Added 5.32%	4,519,377 $45.1 Million
Q1 2023 May 12, 2023	BUY	$8.56 - $13.26 $1.27 Million - $1.97 Million	148,612 Added 3.59%	4,291,140 $38.1 Million

Q4 2022 Feb 13, 2023	BUY	$9.86 - $14.59 $4.14 Million - $6.12 Million	419,438 Added 11.27%	4,142,528 $45.5 Million
Q3 2022 Nov 14, 2022	BUY	$12.33 - $19.81 $4.53 Million - $7.28 Million	367,743 Added 10.96%	3,723,090 $48.5 Million
Q2 2022 Aug 12, 2022	BUY	$7.88 - $14.82 $6.55 Million - $12.3 Million	830,704 Added 32.9%	3,355,347 $42.5 Million
Q1 2022 May 12, 2022	SELL	$12.94 - $29.65 $300,440 - $688,413	-23,218 Reduced 0.91%	2,524,643 $35.4 Million
Q4 2021 Feb 10, 2022	BUY	$26.43 - $34.5 $1.7 Million - $2.22 Million	64,288 Added 2.59%	2,547,861 $73.8 Million
Q3 2021 Nov 09, 2021	BUY	$22.71 - $36.69 $9.01 Million - $14.6 Million	396,957 Added 19.02%	2,483,573 $74.4 Million
Q2 2021 Aug 11, 2021	BUY	$24.21 - $35.89 $50.5 Million - $74.9 Million	2,086,616 New	2,086,616 $55.4 Million

Others Institutions Holding NRIX

# of Institutions

144

Shares Held

50.2M

Call Options Held

30.3K

Put Options Held

22.7K

View Full List

About Nurix Therapeutics, Inc.

Ticker NRIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,147,800
Market Cap $984M
Description
Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...

More about NRIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account